Convenient tumor 3D spheroid arrays manufacturing <i>via</i> acoustic excited bubbles for <i>in situ</i> drug screening.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36752157.
- Also identified by DOI 10.1039/d2lc00973k.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The quick and convenient fabrication of <i>in vitro</i> tumor spheroids models has been pursued for clinical drug discovery and personalized therapy. Here, uniform three-dimensional (3D) tumor spheroids are quickly constructed by acoustically excited bubble arrays in a microfluidic chip and performed drug response testing <i>in situ</i>. In detail, bubble oscillation excited by acoustic waves induces second radiation force, resulting in the cells rotating and aggregating into tumor spheroids, which obtain controllable sizes ranging from 30 to 300 μm. These spherical tumor models are located in microfluidic networks, where drug solutions with gradient concentrations are generated from 0 to 18 mg mL<sup>-1</sup>, so that the cell spheroids response to drugs can be monitored conveniently and efficiently. This one-step tumor spheroids manufacturing method significantly reduces the model construction time to less than 15 s and increases efficiency by eliminating additional transfer processes. These significant advantages of convenience and high-throughput manufacturing make the tumor models promising for use in tumor treatment and point-of-care diagnosis.
Medical subject headings
- Microfluidics
- Drug Discovery